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ABSTRACT 
Whilst elevations in basal cortisol levels have been reported among individuals at-risk for 
psychosis, the extent to which this represents hyperresponsivity of the hypothalamic-pituitary-
adrenal (HPA) axis to psychosocial stressors encountered in the natural environment is currently 
unclear. We aimed to examine stressor-cortisol concordance among youth at clinical high-risk 
(CHR) for psychosis in the North American Prodrome Longitudinal Study 2 (NAPLS 2) and the 
relationship with clinical outcome. At baseline, CHR (N=457) and healthy (N=205) individuals 
provided salivary cortisol samples and completed daily stressor, life event, and childhood 
trauma measures. CHR youth were categorised as remitted, symptomatic, progression of 
positive symptoms, or psychosis conversion at the two-year follow-up. Within-group regression 
models tested associations between psychosocial stressors and cortisol; standardised beta 
coefficients (Stϐ) were subsequently derived to enable within-group pooling of effect sizes 
across stressor types. After adjustment for potential confounders, all CHR subgroups reported 
greater exposure to life events and daily stressors, and more distress in relation to these events, 
relative to controls. All CHR groups were also more likely to experience childhood trauma; only 
CHR converters, however, were characterised by elevated basal cortisol. Daily stressor distress 
was significantly associated with cortisol in controls (ϐ = 0.60, 95% CI: 0.12–1.08) and CHR youth 
who converted to psychosis (ϐ = 0.91, 95% CI: 0.05–1.78). In controls only, life event exposure 
was associated with cortisol (ϐ = 0.45, 95% CI: 0.08–0.83). When pooled across stressors, 
stressor-cortisol concordance was substantially higher among CHR converters (Stϐ = 0.26, 95% 
CI: 0.07 to 0.44) relative to CHR progressed (Stϐ = 0.02, 95% CI: -0.11 to 0.15), symptomatic (Stϐ 
= 0.01, 95% CI: -0.11 to 0.12), and remitted groups (Stϐ = 0.00, 95% CI: -0.13 to 0.13); however, 
unexpectedly, healthy controls showed intermediate levels of concordance (Stϐ = 0.15, 95% CI: 
0.05 to 0.26). In conclusion, whilst all CHR subgroups showed increased psychosocial stress 
exposure and distress relative to controls, only those who later converted to psychosis were 
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characterised by significantly elevated basal cortisol levels. Moreover, only CHR converters 
showed a higher magnitude of stressor-cortisol concordance compared to controls, although 
confidence intervals overlapped considerably between these two groups. These findings do not 
support the notion that all individuals at CHR for psychosis show HPA hyperresponsiveness to 
psychosocial stressors. Instead, CHR individuals vary in their response to stressor 
exposure/distress, perhaps driven by genetic or other vulnerability factors.  
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1. Introduction 
Originally formulated over twenty years ago, and recently updated, the neural diathesis-
stress model proposes that the hypothalamic-pituitary-adrenal (HPA) axis is the central 
physiological mechanism linking psychosocial stress to the onset and exacerbation of 
schizophrenia and related psychotic disorders (Pruessner et al., 2017; Walker et al., 2008; 
Walker and Diforio, 1997). A central tenet to this model is that individuals with increased 
vulnerability for psychosis are more sensitive to the effects of psychosocial stressors due to 
abnormalities within the HPA axis (e.g., HPA hyperactivity/dysregulation or increased 
glucocorticoid sensitivity) which in turn contribute to dopaminergic and glutamatergic 
abnormalities that eventually trigger expression of psychotic illness (Pruessner et al., 2017). In 
support of the model, accumulated evidence indicates that patients with psychosis exhibit 
elevated basal cortisol relative to healthy controls (Borges et al., 2013; Girshkin et al., 2014; 
Hubbard and Miller, 2019), but a blunted cortisol awakening response [CAR (Berger et al., 2016; 
Borges et al., 2013)], the latter thought to represent a distinct HPA axis component, 
independent of stress-induced cortisol secretion (Boehringer et al., 2015). More recently, these 
features have been reported among individuals who are at increased risk for psychosis due to 
clinical features and/or genetic liability (Chaumette et al., 2016; Cullen et al., 2014b; Day et al., 
2014; Mittal et al., 2007; Walker et al., 2001; Yildirim et al., 2011). Moreover, at-risk individuals 
who later develop full psychosis show even greater increases in basal cortisol (Walker et al., 
2010; Walker et al., 2013) and pituitary volume (Saunders et al., 2019), suggesting that 
increased HPA axis activity may signal risk for worsening illness.  
In parallel with this research, studies show that at-risk individuals report greater exposure 
and sensitivity to a range of psychosocial stressors, including major life events, childhood 
trauma, and minor daily stressors (Cullen et al., 2014a; Fusar-Poli et al., 2017; Kelleher et al., 
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2008; Mayo et al., 2017; Myin-Germeys et al., 2001; Palmier-Claus et al., 2012; Peh et al., 2019; 
Tessner et al., 2011; Trotman et al., 2014). However, there has been a paucity of studies 
examining the concordance between psychosocial stressor exposure/distress and HPA axis 
function; as such, the extent to which individuals on the psychosis spectrum exhibit ‘abnormal’ 
HPA axis responses to psychosocial stressors is unclear. That is, the increases in basal cortisol 
observed in those with, and at-risk for, psychosis may represent either (a) a ‘normal/adaptive’ 
response to the high levels of psychosocial stressors reported in these populations (i.e., 
concordance being similar to healthy individuals), or (b) hyperresponsivity of the HPA axis 
(perhaps due to genetic or early life factors), characterised by an increase in cortisol greater 
than that expected in a healthy individual (i.e., increased concordance). Alternatively, the 
elevated basal cortisol levels observed may be partially independent of psychosocial stress 
exposure/distress (i.e., no concordance), and instead reflect individual-level factors such as 
genetic predisposition to HPA axis hyperactivity (Hartling et al., 2019; Pagliaccio et al., 2015; 
Starr et al., 2019) or metabolic abnormalities (e.g., glucose metabolism, which is regulated by 
the HPA axis), the latter being more common among individuals at clinical high-risk (CHR) for 
psychosis (Cadenhead et al., 2019), who present features consistent with the prodromal phase 
of illness.   
Two recent studies of at-risk individuals support the ‘increased concordance’ hypothesis: 
Using the experience sampling method, siblings of psychosis patients showed more pronounced 
increases in salivary cortisol in response to unpleasant events relative to controls (Collip et al., 
2011), whilst a further study reported a stronger association between retrospectively-reported 
stressful life events and basal cortisol in CHR youth compared to controls (Labad et al., 2015). In 
contrast, lower (i.e., blunted) cortisol responses during psychosocial stressor tasks have 
observed in CHR individuals (Pruessner et al., 2013) and young adults with high schizotypy traits 
(Walter et al., 2018) relative to controls; a pattern consistent with that observed in patients with 
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chronic schizophrenia (Zorn et al., 2017). Together, these findings tentatively suggest that 
naturally-occurring psychosocial stressors are associated with greater cortisol increases in at-risk 
individuals compared to healthy controls, whereas the response to experimentally-induced 
psychosocial stressors is blunted. However, the degree to which HPA axis responses to 
laboratory-based stressor tasks (which have low ecological validity) are relevant to psychosis 
aetiology is unclear. 
Studying the effect of naturally-occurring stressors on HPA axis function is methodologically 
complex. Unlike studies using experimentally-induced stressor tasks, the lapse of time between 
stressor exposure and cortisol measurement may be considerable. Whilst elevations in cortisol 
levels following stressor exposure appear to decrease over time (Miller et al., 2007), early life 
events and trauma exposure are associated with HPA dysregulation later in life, suggesting long 
term effects of stress exposure (Pruessner et al., 2017; Walker et al., 2008; Walker and Diforio, 
1997). A related issue is that stress measures and cortisol samples may not be collected on the 
same day, particularly when studies have large assessment batteries spanning several days. It is 
possible that day-to-day variations in perceived stress might influence both retrospective 
reporting of stressful events (and associated distress) and cortisol levels, such that greater 
concordance is observed when measures are collected on the same day. However, to our 
knowledge, this has yet to be investigated.   
Determining the extent to which HPA axis responsivity in at-risk youth predicts clinical 
outcome is important, as such work might ultimately help to identify individuals at increased 
risk of illness progression by virtue of being more sensitive to the effects of psychosocial stress, 
enabling targeted interventions. Utilising data from the North American Prodrome Longitudinal 
Study 2 [NAPLS 2, (Addington et al., 2012)] we investigated whether psychosocial stressors, 
basal cortisol levels, and stressor-cortisol concordance (i.e., the  magnitude of association 
8 
 
 
between psychosocial stressors and cortisol) at the baseline assessment differed across healthy 
controls and CHR subgroups defined on the basis of their clinical presentation at the two-year 
follow-up (remitted, symptomatic, progression of positive symptoms, and converted to 
psychosis). Based on previous studies, we hypothesised that CHR youth who later converted to 
psychosis would show (a) greater exposure and distress in relation to psychosocial stressors, (b) 
elevated basal cortisol, and (c) higher stressor-cortisol concordance relative to healthy controls; 
we also anticipated that CHR non-converters would be intermediate to CHR converters 
subgroups and healthy controls (i.e., converters > positive symptom progression > symptomatic 
> remitted > controls) on these measures. In all analyses we controlled for a range of potential 
confounders (age, sex, medication exposure, and cannabis use), and additionally explored the 
effect of lapse-of-time between assessments on stressor-cortisol concordance. 
2. Materials and Methods 
2.1. Sample  
NAPLS 2 is a consortium of eight research sites examining CHR youth, the aims and 
recruitment methods for which are detailed elsewhere (Addington et al., 2012). Briefly, CHR 
subjects were help-seeking individuals who met criteria for one or more prodromal syndromes: 
(a) attenuated psychotic symptoms; (b) brief intermittent psychotic symptoms; or (c) substantial 
functional decline combined with a first-degree relative with a psychotic disorder, or schizotypal 
personality disorder in individuals younger than 18 years. Prodromal syndromes were assessed 
using the Criteria of Prodromal Syndromes (COPS), based on the Structured Interview for 
Prodromal Syndromes [SIPS (McGlashan et al., 2010)], conducted by clinically-trained 
interviewers; psychiatric diagnoses were determined via the Structured Clinical Interview (SCID) 
for DSM-IV (First et al., 1995). CHR individuals who had met criteria for an Axis I psychotic 
disorder were not eligible for inclusion; treatment with antipsychotic medication was permitted 
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provided that full psychotic symptoms were not present at the time of medication 
commencement. Healthy controls (HC) were recruited from the community and had no personal 
history or first-degree relative with psychosis and did not meet criteria for any prodromal 
syndrome. All participants were aged between 12 – 35 years at recruitment. Exclusion criteria 
for both groups included substance dependence in the past six months, neurological disorder, or 
full-scale IQ < 70. Non-psychotic psychiatric disorders were permitted in CHR and healthy 
control groups (Addington et al., 2017).    
2.2. Procedure 
Ethical approval was provided by Institutional Review Boards at each NAPLS site (Addington 
et al., 2012), all participants provided informed consent or assent. The current sample includes 
662 participants for whom variables of interest at baseline (salivary cortisol and at least one of 
the stress measures examined in the current study) and clinical status at follow-up were 
available. At baseline, participants provided information on sociodemographic factors and 
potential confounders, completed stress measures, and collected saliva samples. Baseline 
assessments were completed over two or more visits. Where possible, saliva was collected on 
the same day as daily stressor, life event and childhood trauma measures (achieved in 50%, 
40%, and 38% of cases, respectively). However, in some in cases (16%), the baseline assessment 
was interrupted (e.g., due to clinical crises or other life changes) that lead to a substantial delay 
(> 2 months) in the completion of all measures. In such instances, the remaining baseline 
measures were collected when the participant was able to return and complete the schedule, 
with clinical assessments repeated to confirm CHR status. All participants were included in the 
analysis which accounted for time-lapse between assessments. Prodromal symptoms were 
assessed via the SIPS at 12- and 24-month follow-up assessments and used to categorise CHR 
subgroups [see Table 1 for details (Addington et al., 2019; Walker et al., 2013)].   
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[Insert Table 1 here] 
2.3. Sociodemographic factors and potential confounders assessed at baseline 
Participant date of birth, sex, and ethnicity were assessed via self-report, the latter was 
subsequently collapsed to a four-level variable (white, black African/African Caribbean, 
Asian/Middle Eastern, other). Cannabis use was assessed via a structured interview (Buchy et 
al., 2015). For the purposes of the current investigation we created a binary variable indexing 
current use (no/yes). Details of all prescribed psychotropic medications (type, name, dosage, 
and frequency) were obtained at the baseline assessment via self-report, pharmacy records, 
and/or medical records. Binary variables (no/yes) were created for current antipsychotic use 
and current psychotropic use (non-antipsychotics), irrespective of type, dose, or data source. 
2.4. Stress measures 
The 58-item, Daily Stress Inventory (Brantley et al., 1987), was used to determine the 
presence of minor stressors (e.g., ‘Performed poorly at task’, ‘Was ignored by others’) occurring 
within the past 24-hours. Participants indicated whether they experienced each stressor and the 
level of distress elicited by each endorsed stressor (scored on a 7-point scale: 1 ‘occurred but 
was not stressful’ to 7 ‘caused me to panic’). Total distress scores (range: 0-406) were then 
divided by the total exposure score (range: 0-58) to obtain an average distress per item score 
(range: 0-7).  
Life events (e.g., ‘End of romantic relationship’, ‘Loss of job’) were assessed via the 
Psychiatric Epidemiology Research Interview Life Events Scale (Dohrenwend et al., 1978), 
modified to exclude life events of lesser relevance to youth (e.g., divorce and financial losses) 
(Trotman et al., 2014). The 59 events can be classified as independent or dependent (of an 
individual’s influence/behaviour). Interviewers recorded how often each of the 59 events had 
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occurred in the participant’s lifetime and the associated level of distress (scored using the same 
7-point scale described above); participants could report multiple exposures to the same event 
(distress on each occasion also recorded), where the maximum occurrence for any single life 
event in the NAPLS cohort was four. An average life event distress score (range: 0-7) was 
derived by dividing the total distress score (potential range: 0-1652) by the total exposure score 
(potential range: 0-236).  
Participants additionally completed the Childhood Trauma and Abuse Scale (Janssen et al., 
2004), a semi-structured interview examining experiences of physical, sexual, and psychological 
abuse, and emotional neglect, occurring prior to age 16 (Addington et al., 2013). Each trauma 
type was scored as absent/present with a binary variable indexing any form of trauma derived.  
2.5. Salivary cortisol  
At the research session, participants provided three saliva samples (one per hour) with a 
mean salivary cortisol value subsequently derived when two or more samples were available 
(participants with only one sample were excluded). The median time of collection for the three 
samples was 1107 h (range: 0615-1811), 1207 h (range: 0645-1956), and 1300 h (range: 0715-
1946), respectively. The mean cortisol value, which is highly correlated with area under the 
curve (AUC) values (Walker et al., 2010), was computed to provide consistency with previous 
publications (Walker et al., 2013). Participants were instructed to avoid consumption of 
caffeine, alcohol, or dairy products after 1900 h on the day before sampling; individuals who 
reported non-compliance with these instructions were not excluded as previous analyses 
performed on a subset of the cohort found no association with these variables and cortisol 
levels (Walker et al., 2013). Use of non-prescription medications (corticosteroids, 
antihistamines, diet pills, cough/cold medicine) over the past 24 hours was assessed via self-
report. Samples were stored at -20° C, and rapidly thawed and centrifuged prior to assay using a 
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highly sensitive enzyme immunoassay (Salimetrics, State College, Pennsylvania). All samples 
were assayed in duplicate with intra- and inter-assay coefficients of variation less than 10% and 
15%, respectively.  
2.6. Data analyses  
All analyses were performed using Stata Version 15 (StataCorp, 2017). The number of days 
between stress measure completion and cortisol collection could not be computed for ~6% of 
the sample due to missing assessment dates. In such cases, missing values for the three time-
lapse variables were imputed using the median number of days (daily stressor and cortisol = 0 
days, life events and cortisol = 1 day, childhood trauma and cortisol = 2 days) across the entire 
sample. The imputed data variables were used in all subsequent analyses.  
Ladder and gladder commands were used to identify transformations yielding normally 
distributed continuous variables. Subsequently, age, cortisol, daily stressor average distress 
scores, and life event exposure scores were log-transformed, daily stressor exposure scores 
were square-root transformed, whilst life event average distress scores did not require 
transformation. There were no transformations that could improve the distribution of the 
assessment time-lapse variable, therefore a five-level categorical variable was created (1) 
cortisol collected before stress measurement; (2) assessments completed on the same day; (3) 
cortisol 1-10 days after stress measurement; (4) cortisol 11-30 days after; and (5) cortisol > 30 
days after). Next, we examined correlations between salivary cortisol and sampling variables, 
namely, time of first sample collection, number of samples collected (two only vs. all three), and 
use of non-prescription medications in past 24 hours. To remove the influence of relevant 
factors (those associated with cortisol at the p < 0.05 level), cortisol values for the entire sample 
were regressed on sampling time, cough/cold medication use, and corticosteroid use to obtain 
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standardised residuals. The resulting (normally distributed) variable was used for all subsequent 
analyses. 
Group differences in demographic variables were examined using one-way analysis of 
variance, Kruskall Wallis, and chi-squared tests. To identify potential confounders, associations 
among demographic factors, cortisol, and psychosocial stress measures were examined using 
within-group Pearson’s correlations (for continuous - continuous pairings), biserial correlations 
(for continuous - categorical pairings), and chi-squared tests (for categorical - categorical 
pairings). Associations of group status with basal cortisol and psychosocial stressors were next 
examined, with adjustment for factors that were found in the above steps to be significantly 
associated with basal cortisol and/or any stressor in any group. Analyses of covariance 
(ANCOVA), were employed for basal cortisol and continuous stressor measures, with estimated 
means and standard errors (SE) derived from these models. For trauma exposure, a logistic 
regression model was used to test the association with group status (testparm command); 
pairwise comparisons and adjusted trauma prevalence rates and associated SEs for each group 
were derived from the logistic model. All pairwise comparisons were performed with Sidak 
correction for multiple testing.     
To test whether stressor-cortisol concordance was moderated by time-lapse between 
assessments, correlations between cortisol and psychosocial stressors were examined within 
each time-lapse category. Linear regression models were used to test associations between 
individual psychosocial stressors (predictor variables) and salivary cortisol (outcome variable) in 
each group. Owing to multicollinearity, each stressor was examined in a separate model; all 
models were adjusting for potential confounders identified in the above steps. To facilitate 
comparison of stressor-cortisol concordance across groups, from these adjusted models, we 
obtained standardised beta coefficients (Stϐ) for each psychosocial stress measure and 
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computed SEs for these coefficients [SEStϐ = SEϐ (Stϐ/ϐ)]. Stϐ coefficients for each stressor were 
then pooled using the ‘meta’ command (random effects) to obtain an overall measure of 
stressor-cortisol concordance.  
3. Results  
3.1. Sociodemographic characteristics 
Of the 457 CHR individuals included in the current study, 134 (29.3%) showed a remission 
of CHR symptoms, 130 (28.4%) remained symptomatic, 124 (27.1%) experienced a progression 
of positive symptoms, and 69 (15.1%) converted to psychosis. The groups did not differ on sex 
or ethnicity (Table 2); however, there was a relation of follow-up status with age (F2,726 = 5.04, p 
= 0.001), with post-hoc tests indicating that CHR individuals whose symptoms remitted were 
significantly younger than controls at baseline. Group status was significantly associated with 
both antipsychotic use (χ2=36.66, p < 0.001) and any other psychotropic use (χ2= 83.33, p = 
0.001) at baseline; in both cases, individual chi-squared tests indicated that all four CHR groups 
were more likely to be treated with medication relative to controls but did not differ from each 
other. The same pattern was observed for cannabis use, whereby a significant overall 
association was observed between current use and group status (χ2=17.61, p = 0.001) with 
individual tests showing that current cannabis use was more common among all CHR groups 
relative to controls but that the prevalence did not differ across CHR subgroups. Non-parametric 
Kruskal Wallis (KW) tests performed on the continuous time-lapse variable indicated that the 
groups did not differ on the lapse-of-time between cortisol collection and daily stressor 
assessment (KW χ2= 5.47, p = 0.243), cortisol collection and life event assessment (KW χ2= 4.68, 
p = 0.321), or cortisol collection and trauma assessment (KW χ2= 8.48, p = 0.076). 
[Insert Table 2 here] 
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3.2. Potential confounders 
Age was positively associated with life event exposure and life event distress in controls 
and all four CHR groups, with daily stressor distress in CHR remitted, symptomatic, and 
progressed groups, and with cortisol in controls, CHR remitted, and CHR converted groups (p < 
0.05 for all). Female sex was likewise positively associated with life event exposure in controls, 
daily stressor exposure in the CHR remitted group, daily stressor distress in CHR symptomatic 
individuals, and with all five psychosocial stressor measures in the CHR progression of positive 
symptoms group. In contrast, ethnicity (recoded as white vs. non-white) was not associated with 
any stress measure or cortisol in any group. With regards to psychotropic medication, 
antipsychotic use at baseline was negatively correlated with daily stressor exposure in the CHR 
remitted group and with life event exposure and trauma in the CHR progressed group, but 
positively associated with daily stressor distress in CHR individuals who later converted to 
psychosis; similarly, other psychotropic medication was negatively correlated with daily stressor 
exposure in the remitted group but positively correlated with daily stressor and life event 
distress variables in the converter group. Current cannabis use was associated positively with 
daily stressor exposure, life event distress, and trauma in the control group and with life event 
exposure in remitted and symptomatic groups.  
The above analyses identified the following baseline factors as potential confounders in the 
relationship between stress and cortisol: age, sex, current antipsychotic use, current other 
psychotropic medication use, and current cannabis use. However, owing to multicollinearity 
issues (current antipsychotic and other psychotropic medication use were strongly associated: 
χ2= 94.89, p < 0.001), all models included antipsychotic use only as a covariate, with sensitivity 
analyses performed using other psychotropic medication in place of antipsychotic use. We were 
additionally concerned that controlling for current cannabis use might obscure important 
16 
 
 
relationships between stress and cortisol (Miller and Chapman, 2001), given that recent 
evidence indicates that stress can precipitate cannabis use in healthy and clinical samples 
(Hyman and Sinha, 2009), and therefore included cannabis use as a covariate in sensitivity 
analyses only.  
3.3. Group differences in cortisol and psychosocial stressors  
ANCOVAs (basal cortisol, continuous stress measures) and logistic regression (trauma 
exposure) indicated significant main effects of group status on basal cortisol (p = 0.013) and all 
stress measures (p < 0.001) after adjustment for age, sex, and antipsychotic use at baseline 
(Table 3). Post-hoc comparisons (Sidak-corrected) indicated that only CHR convertors were 
characterised by elevated basal cortisol compared to controls (t=3.19, p=0.015), no other group 
differences were observed. With regards to continuous stress measures (daily stressor exposure 
and distress scores and life event exposure and distress scores), all four CHR subgroups were 
characterised by significantly higher scores relative to controls; for daily stressor exposure only, 
symptomatic, progressed, and converted groups also showed significantly higher scores relative 
to remitted CHR youth. To confirm that the greater exposure to life events observed in CHR 
subgroups was not simply due to events that could be caused by illness, we additionally 
compared groups on exposure to independent life events (data not shown) and observed a 
significant main effect of group status (F=10.86, p<0.001). Post-hoc tests indicated that all CHR 
subgroups, except for the remitted group, reported increased exposure to independent life 
events compared to controls. Finally, childhood trauma was more common in all CHR groups 
compared to controls but did not distinguish among CHR subgroups. All results were largely 
unchanged when (a) cannabis use was included as an additional covariate and (b) other 
psychotropic medication use was additionally included in place of antipsychotic medication, 
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with the exception that CHR remitted youth no longer showed significantly greater life event 
exposure compared to controls.  
[Insert Table 3 here] 
3.4. Stressor-cortisol concordance by time lapse between assessments 
In line with predictions, stressor-cortisol concordance varied according to the lapse-of-time 
between assessments (see Figure 1): When acquired on the same day as saliva sampling, all 
stress measures showed significant, positive correlations with cortisol (p < 0.05), except for life 
event distress scores which were positively correlated but not significantly. In contrast, stress 
measures were not significantly correlated with cortisol in any other time-lapse category except 
for life event exposure and cortisol which were positively associated when the lapse-of-time was 
31 days or longer. To account for the moderating effect of time-lapse between assessments, 
interaction terms (stress*time-lapse) were additionally included in subsequent regression 
models. 
[Insert Figure 1 here] 
3.5. Stressor-cortisol concordance by clinical status at follow-up 
Within-group linear regression analyses were performed (Table 4) to examine stressor-
cortisol concordance after adjustment for potential confounders and the interaction between 
stressors and lapse-of-time between assessments. Daily stressor distress was significantly 
associated with cortisol in both controls (ϐ = 0.60, 95% CI: 0.12 to 1.08) and CHR converters (ϐ = 
0.91, 95% CI: 0.05 to 1.78). In the control group only, greater life event exposure was associated 
with higher cortisol (ϐ = 0.45, 95% CI: 0.08 to 0.83). In contrast, none of the stress measures 
were significantly associated with cortisol in the CHR remitted, symptomatic, or progressed 
subgroups. Sensitivity analyses (data not shown) indicated that there was no change to the 
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overall pattern of findings when cannabis use was included as an additional covariate or when 
any psychotropic use was used in place of antipsychotic use. Moreover, when we additionally 
adjusted all models for exposure to dependent life events, results were unchanged. When Stϐ 
coefficients were pooled across all five stress measures, stressor-cortisol concordance was 
highest in the CHR converted group (Stϐ = 0.26, 95% CI: 0.07 to 0.44), intermediate in controls 
(Stϐ = 0.15, 95% CI: 0.05 to 0.26), and lowest in the CHR progressed (Stϐ = 0.02, 95% CI: -0.11 to 
0.15), symptomatic (Stϐ = 0.01, 95% CI: -0.11 to 0.12), and remitted groups (Stϐ = 0.00, 95% CI: -
0.13 to 0.13). Figure 2 illustrates the pattern of pooled stressor-cortisol across groups; whilst 
confidence intervals for CHR converted and healthy control groups overlapped substantially, the 
former were clearly distinguished from non-converted CHR subgroups (Cumming, 2009). 
[Insert Table 4 and Figure 2 here] 
4. Discussion 
The current study aimed to further characterise the nature of HPA axis abnormalities 
among individuals at-risk for psychosis by examining psychosocial stressors, basal cortisol, and 
the concordance between these measures in a large sample of CHR youth categorised according 
to clinical status at the two-year follow-up. In line with hypotheses, all CHR groups, were 
characterised by significantly greater psychosocial stressor exposure and distress relative to 
healthy controls; however, only those who converted to psychosis demonstrated elevated basal 
cortisol levels. In contrast to expectations, whilst CHR converters showed the greatest degree of 
stressor-cortisol concordance when pooled across stressors, confidence intervals substantially 
overlapped with the control group and the degree of concordance among CHR youth who 
remitted, remained symptomatic, or whose positive symptoms had progressed at follow-up was 
lower than that observed in the control group.   
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After adjustment for potential confounders (including dependent life events) and 
correction for multiple testing, only CHR converters showed elevated basal cortisol relative to 
healthy controls. This finding cannot be simply attributed to greater stressor exposure or 
distress experienced by CHR converters relative to controls, as these features characterised all 
CHR subgroups. This elevation might instead reflect an amplification of the normative 
adolescent increase in cortisol secretion (Apter et al., 1979; Marceau et al., 2015), or metabolic 
abnormalities [more common among CHR youth (Cadenhead et al., 2019)], independent of 
stress exposure. Consistent with a recent meta-analysis (Chaumette et al., 2016), pairwise 
comparisons showed that basal cortisol levels did not distinguish CHR converters from CHR non-
converters. Whilst this suggests that within the CHR population, baseline cortisol levels do not 
signal risk for psychosis transition, repeated measurement of cortisol is needed to determine 
whether longitudinal increases predict poorer outcomes in this group. Moreover, it should be 
assumed that at 2-year follow-up there are some false negative cases in the CHR non-converted 
groups (Ziermans et al., 2014), and thus differences between converters and non-converters 
may increase with a longer follow-up period. 
We predicted that the degree of stressor-cortisol concordance, when pooled across 
stressors, would increase in parallel with the level of symptom expression at follow-up (i.e., 
controls < remitted < symptomatic < progression of psychotic symptoms < converters). Whilst 
the highest degree of concordance was indeed observed among the CHR converters, the control 
group was intermediate, and pooled beta coefficients in the three non-converted CHR 
subgroups were approximately zero (indicating no significant association between stressor 
measures and basal cortisol). Moreover, confidence intervals for pooled stressor-cortisol 
concordance estimates for all CHR subgroups (particularly the converter group) showed a high 
degree of overlap with the control group (Figure 2); it has been proposed that for many effect 
sizes, confidence intervals overlapping by greater than 50% suggests that effect sizes are not 
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significantly different (Cumming, 2009). Thus, none of the CHR subgroups showed significant 
hyper or hypo-responsivity of the HPA axis in response to psychosocial stressors encountered in 
the natural environment when compared to controls. Stressor-cortisol concordance was, 
however, substantially higher among CHR converters compared to all other CHR subgroup (i.e., 
confidence intervals appeared to overlap < 50%). This finding is consistent with the only 
previous study to examine the relationship between stressor-cortisol concordance and outcome 
status in CHR individuals: Labad and colleagues similarly reported a moderate-to-strong (but not 
statistically significant) correlation between salivary cortisol and stressful life events among 
those who later transitioned to psychosis, but only a weak correlation in the non-transitioned 
CHR group (Labad et al., 2015).  
Overall, we found few significant associations between individual stressors and basal 
cortisol across all groups (Table 4). Whilst this could be due to the HPA axis and/or stress 
measures employed, previous studies of at-risk youth which have used different measures have 
likewise found inconsistent associations between stress and cortisol (Cullen et al., 2014b; Labad 
et al., 2015; Thompson et al., 2007). Similarly, in healthy subjects, correlations between self-
reported stress and cortisol have not been observed (Cummins and Gevirtz, 1993; Vedhara et 
al., 2003). Although the exact mechanisms underlying HPA responsivity to stress are unknown 
(and likely complex), it has been demonstrated that there are individual differences in 
responsivity that are partially determined by genetic variants (e.g., FKBP5, CRHR1, NR3C1, 
NR3C2) that modify the effect of acute and chronic stress/trauma on cortisol levels in healthy 
adolescents and adults (Hartling et al., 2019; Starr et al., 2019; Utge et al., 2018) and patients 
with psychosis (Mondelli and Ciufolini, 2017). Thus, genetic and other vulnerability factors are 
likely responsible for the different patterns of association between stressors and cortisol that 
we observed across both individual stressor types and, when pooled across stressors, CHR 
subgroups.  
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4.1. Limitations 
Despite the large overall sample size, individual CHR subgroups were notably smaller 
(particularly the converted group) thereby reducing our ability to detect statistically significant 
associations between psychosocial stressors and cortisol. Conversely, as we did not adjust for 
multiple comparisons in our primary analyses examining stressor-cortisol concordance, some 
significant associations may have arisen by chance. However, we tested specific a priori 
hypotheses and were largely interested in the overall pattern of stressor-cortisol concordance 
rather than statistical significance. Moreover, we adjusted for a range of potential confounders 
which, had we not accounted for these variables, would have led to spurious associations. A 
further limitation is that a small proportion of participants (16%), experienced a long delay (> 
two months) between baseline assessment visits, which led to a large lapse-of-time between 
completion of psychosocial stressor assessments and cortisol collection. Including these 
participants in the analyses increased statistical power to test the moderating effect of time-
lapse on stressor-cortisol concordance. One major limitation is that we examined only three 
stressor types. There are a range of other stressors relevant to psychosis that might conceivably 
impact on HPA axis function (e.g., urbanicity, neighbourhood cohesion, and socioeconomic 
deprivation); it is possible that examining a wider range of stressors might yield different 
patterns of stressor-cortisol concordance across CHR subgroups. Similarly, our findings are 
specific to basal salivary cortisol, other measures (e.g., plasma cortisol or salivary diurnal or 
awakening cortisol profiles) may have produced different results.  
Whilst the aim of our study was to examine the relationship between baseline features 
(psychosocial stressors, basal cortisol, and stressor-cortisol concordance) and subsequent 
outcome (based on progression to psychosis), it is important to note that there are limitations 
with this approach. First, we did not account psychosocial stressors and other confounding 
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factors/events that may have occurred in the time between baseline and follow-up. Indeed, it is 
possible that stressor-cortisol concordance at follow-up does in fact distinguish between CHR 
subgroups, but that our measure at baseline was too distal to outcome. Second, CHR individuals 
are at elevated risk for a wide range of psychiatric disorders, particularly depression and anxiety 
(Addington et al., 2017; Addington et al., 2019), and so worsening of prodromal 
symptoms/transition to psychosis is only one of several potential outcome measures, all of 
which will inevitably involve more false negatives the shorter the follow-up period. Indeed, a 
recent study suggested that well-established risk factors are better at predicting poor 
functioning in CHR populations than transition to psychosis (Zhang et al., 2019). The extent to 
which stressor-cortisol concordance at baseline is associated with other non-psychotic disorders 
and functioning at follow-up is therefore warranted.   
4.2. Directions for future research 
We assessed HPA axis function using basal salivary cortisol collected in the laboratory, as it 
is more reliable and, unlike home sampling methods, unlikely to be influenced by confounding 
factors such as exercise (Hill et al., 2008; Laceulle et al., 2015), and found positive associations 
with psychosocial stressors in both CHR converters and healthy controls. However, meta-
analytic evidence indicates that the effect of chronic stress on cortisol varies across cortisol 
measures; whilst diurnal (overall daily output) cortisol, afternoon/evening cortisol, and the CARi 
(increase in cortisol following awakening) are elevated following chronic stress, basal morning 
levels are lower and the diurnal rhythm appears to be flatter (Chida and Steptoe, 2009; Miller et 
al., 2007). Employing alternative cortisol measures might therefore reveal different patterns of 
stressor-cortisol concordance across CHR individuals and controls. Indeed, using a home 
sampling procedure, Cullen and colleagues reported a negative correlation between the CARi 
and negative life event distress in at-risk children with a family history of schizophrenia but a 
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positive correlation in typically-developing children (Cullen et al., 2014b), whilst a study of adults 
found that diurnal cortisol was associated negatively with stressful life event exposure in first-
episode psychosis patients, most of whom were receiving antipsychotic medication, but 
positively in controls (Mondelli et al., 2010). Thus, employing multiple measures of cortisol may 
be more informative than basal cortisol alone and enable the identification of dissociated 
relationships in at-risk individuals/psychosis patients and healthy controls. 
Cortisol output is not, however, the only method of assessing HPA axis function. In addition 
to endocrine measurement (which extends to other HPA-axis hormones, e.g., 
adrenocorticotropic hormone) neuroimaging can be used to determine pituitary and 
hippocampal volume (key structures involved in mediating HPA axis function) and density, 
distribution and/or affinity of glucocorticoid/mineralocorticoid receptors. The latter is 
particularly important as these receptors mediate the effects of glucocorticoids on cellular 
targets. As a related point, future studies are warranted to investigate glucocorticoid 
sensitisation (i.e., the responsiveness to increased glucocorticoids over time), in CHR youth, as 
this may have implications not only for the HPA axis, but also the immune system (Cain and 
Cidlowski, 2017), and dopamine levels (Lefevre et al., 2017). Thus, studies employing multiple 
methodological approaches, including genetic profiling, neuroimaging, and endocrine 
measurement, may be needed to adequately investigate the extent to which individuals at-risk 
for psychosis are characterised by increased HPA axis sensitivity. 
Our findings have other implications for future research examining HPA axis responsivity in 
at-risk individuals. First, we observed that the lapse-of-time between completion of stress 
measures and cortisol collection moderated stressor-cortisol concordance (with minor 
exceptions, significant relationships were observed only when measures were collected on the 
same day). Whilst we anticipated this pattern for daily stressors occurring within the past 24 
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hours, the findings for life events and childhood trauma were not predicted as these events did 
not occur on the day of measurement. It is plausible that reporting these events in the research 
environment is itself a stressful experience for some participants, and that it elicits a cortisol 
elevation and thus a relationship between stressor exposure and cortisol. These findings 
highlight the importance of adjusting for the interaction between stressors and time-lapse 
between assessments when examining stressor-cortisol concordance. Second, participant sex 
was identified as a potential confounder. The updated neural diathesis-stress model noted sex 
differences to be an important area for future research (Pruessner et al., 2017), whilst it was 
beyond the scope of the current study to explore whether sex modified the degree of stressor-
cortisol concordance, future studies should investigate this possibility. Finally, whilst we defined 
CHR outcome status on the basis of attenuated positive symptoms and transition to psychosis, 
as noted above, there has been recent acknowledgement of the need to examine a broader 
range of outcomes, including, levels of social and role functioning, non-psychotic disorders, and 
negative symptoms (Addington et al., 2011; Yung et al., 2019). Future studies might therefore 
examine whether stressor-cortisol concordance is associated with these outcomes at follow-up.  
4.3. Conclusions 
The original neural diathesis-stress model of schizophrenia (Walker and Diforio, 1997) and 
subsequent revisions of this hypothesis (Pruessner et al., 2017; Walker et al., 2008) 
hypothesized that heightened HPA axis activity among those at elevated risk for psychosis could 
be stress-induced, a manifestation of hippocampal dysfunction or glucocorticoid receptor 
abnormalities, or genetically determined. In the current study, we tested the first of these 
possibilities and conclude that the elevation in basal cortisol levels among CHR converters is not 
simply due to increased psychosocial stressor exposure and distress, as the latter was common 
to all CHR subgroups. Our analyses did, however, show that naturally-occurring psychosocial 
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stressors were more strongly associated with basal cortisol levels in CHR converters compared 
to CHR non-converters (perhaps driven by genetic factors), although the degree of concordance 
did not appear to differ significantly in converters and healthy controls. Given the novelty of this 
investigation, this pattern of findings warrants further investigation in other at-risk populations.  
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Figure legends  
Fig. 1. Stressor-cortisol concordance by assessment time-lapse across the total sample. 
Correlations between psychosocial stressors and basal cortisol according to lapse of time 
between stressor assessment and salivary cortisol collection (days).  
 
Fig. 2. Pooled standardised beta coefficients (with 95% confidence intervals), representing the 
magnitude of stressor-cortisol concordance, by group status at follow-up.  
 
Figure notes  
Fig. 1. Number of participants per time-lapse period for (a) daily stressor exposure/distress and 
cortisol: cortisol before stressor (n=26), same day (n=381), cortisol 1-10 days after (n=91), 
cortisol 11-30 days after (n=94), cortisol > 30 days after (n=70); (b) life event exposure/distress 
and cortisol: cortisol before stressor (n=41), same day (n=264), cortisol 1-10 days after (n=152), 
cortisol 11-30 days after (n=107), cortisol > 30 days after (n=98); and (c) trauma exposure and 
cortisol: cortisol before stressor (n=28), same day (n=251), cortisol 1-10 days after (n=144), 
cortisol 11-30 days after (n=135), cortisol > 30 days after (n=104); 
 
 
 
